NATIONAL
CALIFORNIA
VENTURA
category
mechanism
  • Stimulates both adrenergic and dopaminergic receptors, lower doses are mainly dopaminergic stimulating and produce renal and mesenteric vasodilation, higher doses also are both dopaminergic and beta-1 stimulating and produce cardiac stimulation and renal vasodilation; large doses stimulate alpha receptors
indications
  • Hypotension or shock: Treatment of severe hypotension or shock that persists during and after adequate fluid volume replacement.
contraindications
  • Hypersensitivity to sulfites
  • Pheochromocytoma
  • Uncorrected tachyarrhythmias
  • Ventricular fibrillation
dosing

IV: 5 to 15 mcg/kg/minute

administration
IV Continuous Infusion
onset

5 minutes

duration

<10 minutes

notes
  • Appropriate use: Hypovolemia should be corrected before giving dopamine
  • Sodium Bicarbonate: Dopamine may be inactivated by alkaline solutions such as sodium bicarbonate
  • Monoamine oxidase inhibitors (MAO-I): Use with extreme caution in patients taking MAO inhibitors; prolong hypertension may result from concurrent use
dosage form
40 mg/mL (5 mL, 10 mL)
brand name
Intropin
adverse reactions
  • Cardiovascular
    • Arrhythmias, hypertension, hypotension, palpitations
  • Gastrointestinal
    • Nausea, vomiting
  • Nervous system
    • Anxiety, headache
  • Respiratory
    • Dyspnea
structure
dopamine.svg molecular structure